Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.18B | 1.35B | 1.34B | 1.43B | 1.72B | 1.30B | Gross Profit |
785.70M | 840.74M | 896.29M | 885.04M | 837.33M | 866.80M | EBIT |
-32.49M | 127.97M | 242.09M | 260.07M | 256.92M | 373.62M | EBITDA |
83.50M | 256.97M | 398.26M | 467.15M | 383.67M | 547.83M | Net Income Common Stockholders |
-4.75M | 119.54M | 175.03M | 265.87M | 287.52M | 291.13M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
233.86M | 125.15M | 89.79M | 86.14M | 129.14M | 99.30M | Total Assets |
1.10B | 3.40B | 3.37B | 3.36B | 3.52B | 2.95B | Total Debt |
40.19M | 113.70M | 440.33M | 487.29M | 521.67M | 137.19M | Net Debt |
-117.87M | -11.45M | 350.54M | 401.14M | 392.53M | 37.89M | Total Liabilities |
4.58B | 1.44B | 1.04B | 1.11B | 1.29B | 2.81B | Stockholders Equity |
-3.48B | 1.96B | 2.33B | 2.25B | 2.23B | 139.26M |
Cash Flow | Free Cash Flow | ||||
368.50M | 215.37M | 362.24M | 356.79M | 318.53M | 255.13M | Operating Cash Flow |
440.50M | 296.56M | 444.54M | 444.23M | 407.40M | 349.52M | Investing Cash Flow |
-59.27M | -68.47M | -273.62M | -139.44M | -174.57M | -222.32M | Financing Cash Flow |
-666.39M | -192.72M | -167.27M | -347.79M | -203.00M | -168.95M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | $7.18B | 76.10 | 4.66% | ― | 20.03% | 71.43% | |
67 Neutral | $970.55M | 48.69 | 5.72% | 0.36% | 4.51% | 32.28% | |
64 Neutral | $744.43M | 18.99 | 8.25% | ― | 2.65% | 3.34% | |
63 Neutral | $1.78B | 16.39 | 1.76% | 4.30% | -10.24% | -106.48% | |
60 Neutral | $1.59B | 124.63 | 1.03% | ― | -3.04% | ― | |
48 Neutral | $6.86B | 1.11 | -50.22% | 2.47% | 16.71% | 1.53% |
On February 14, 2025, Premier, Inc. entered into agreements with JPMorgan Chase Bank to repurchase $200 million of its Class A common stock. This transaction is part of a $1 billion share repurchase plan approved by Premier’s Board in February 2024. The company funded the repurchase using its credit facility, with the final settlement expected by the first quarter of the 2026 fiscal year. This initiative signifies Premier’s strategic use of capital, potentially enhancing shareholder value and reflecting confidence in its market positioning.
On February 4, 2025, Premier, Inc. announced its fiscal-year 2025 second-quarter financial results for the period ended December 31, 2024. The company reported a GAAP net loss from continuing operations of $45.8 million, influenced by a significant impairment charge. Despite this, Premier reaffirmed its midpoints for fiscal revenue and adjusted EBITDA guidance, and increased its adjusted earnings per share guidance. The results also highlight a $200 million share repurchase, underscoring the company’s commitment to returning capital to shareholders. The report reflects Premier’s ongoing strategic adjustments, including the divestiture of the S2S Global business and the continued inclusion of contributions from Contigo Health, amid challenges in its Performance Services segment.
In January 2025, Premier, Inc. announced the completion of an additional $200 million repurchase of its Class A Common Stock, part of a $1.0 billion share repurchase authorization approved in February 2024. This marks a total of $600 million in repurchases to date, following a $400 million accelerated share repurchase program. This move underscores Premier’s strategic capital allocation aimed at creating value for stockholders. The company is also set to present at the J.P. Morgan Healthcare Conference on January 14, 2025, where it will discuss its growth strategies and positioning in the healthcare industry.